Company news
Essilorluxottica Sa (EURONEXT:EL) news
Essilorluxottica Sa news releases on 6ix. Latest, Sep 28, 2026: EssilorLuxottica: Disclosure of transactions in own shares
Press releases & updates
EssilorLuxottica: Disclosure of transactions in own shares
September 27, 2026
EssilorLuxottica: Déclaration de transactions sur actions propres
September 27, 2026
EssilorLuxottica and Meta further advance AI glasses category with new products revealed at Meta Connect
September 23, 2026
EssilorLuxottica : unveils the best six-month treatment effects ever reported across its clinical studies on Essilor Stellest lenses
September 22, 2026
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026
September 10, 2026
EssilorLuxottica: EssilorLuxottica Board of Directors unanimously reaffirms confidence in the Company’s leadership and strategy
September 9, 2026
EssilorLuxottica: Le Conseil d’administration d’EssilorLuxottica réaffirme à l’unanimité sa confiance dans le management et la stratégie de l’entreprise
September 8, 2026
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
September 3, 2026
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026
September 2, 2026
EssilorLuxottica: Déclaration de transactions sur actions propres
August 30, 2026
EssilorLuxottica : 24-Month U.S. Clinical Trial Results Supporting FDA De Novo Market Authorization of Essilor Stellest Lenses* Published in JAMA Ophthalmology
August 27, 2026
EssilorLuxottica: Publication of the 2026 Interim Financial Report
July 29, 2026
EssilorLuxottica: Q2/H1 2026 Results - Solid revenue trajectory at +9.7% in H1, with Q2 at +8.7%. Increasing profitability, with Adj. Operating Profit +15%.
July 28, 2026
EssilorLuxottica: Second-Quarter and First-Half 2026 Results Conference Call Invitation
July 16, 2026
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2026
July 7, 2026
Malaysia Faces Rising Childhood Myopia Challenge: VISTA Eye Specialist, EssilorLuxottica, UiTM and SK Jalan U3 Join Forces to Protect Children's Vision
July 3, 2026
LensCrafters Enters a New Era of Med-Tech Innovation, Building an Integrated Ecosystem of Care
June 30, 2026
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2026
June 9, 2026
EssilorLuxottica : to start wearable production in Italy
June 9, 2026
EssilorLuxottica : Result of the payment of dividends in shares and record of the corresponding capital increase
June 1, 2026
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
May 12, 2026
EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders’ Meeting
April 28, 2026
EssilorLuxottica: Disclosure of transactions in own shares
April 27, 2026
EssilorLuxottica : acquires the Italian company Faro, advancing high-precision technologies in eyewear manufacturing
April 23, 2026
EssilorLuxottica: Q1 2026 Revenue - Revenue rising 10.8% in Q1. Third consecutive quarter of double-digit growth
April 22, 2026
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026
April 10, 2026
EssilorLuxottica acquires a stake in Top Charoen, reinforcing its presence in Thailand
April 2, 2026
EssilorLuxottica and Meta Expand AI Glasses Portfolio with Ray-Ban Meta Optics Styles
March 31, 2026
EssilorLuxottica and Dolce&Gabbana further strengthen their partnership through 2050
March 16, 2026
EssilorLuxottica's Inaugural SWITCH: Vision Innovation Summit delivers an inspiring deep dive into the future of vision care and healthcare, from AI wearables to breakthroughs in neuroscience
March 12, 2026
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 11, 2026
March 12, 2026
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2026
March 10, 2026
EssilorLuxottica: 2025 Universal Registration Document filed
March 6, 2026
AM Best Affirms Credit Ratings of EyeMed Insurance Company
February 19, 2026
EssilorLuxottica announces the launch of a share buyback program
February 13, 2026
EssilorLuxottica: EssilorLuxottica Board of Directors Proposes Renewal of Eight Directors
February 11, 2026
EssilorLuxottica: Q4/FY 2025 Results - Revenue growing 18.4% in Q4 and 11.2% in the FY. Adj. operating margin at 16.0% in the FY
February 11, 2026
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026
February 10, 2026
EssilorLuxottica: Full-Year 2025 Results Conference Call Invitation
February 2, 2026
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025
January 13, 2026
LensCrafters Continues Dedicated to Everyday Excellence Campaign in 2026 with Award‑Winning Optometrist Dr. Anisha Haji
January 5, 2026
EssilorLuxottica and Burberry announce licensing partnership renewal
December 18, 2025
EssilorLuxottica to acquire Signifeye, further growing its ophthalmology clinics footprint
December 12, 2025
EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate the future of smart eyewear
December 10, 2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2025
December 9, 2025
EssilorLuxottica creates Scientific Advisory Committee to accelerate the next era of innovation
December 1, 2025
Heidelberg Engineering joins the Collaborative Community on Ophthalmic Innovation (CCOI) through EssilorLuxottica’s Vision Architect membership
November 14, 2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2025
November 12, 2025
EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution
November 6, 2025
EssilorLuxottica: Q3/9M 2025 Revenue - Revenue up 11.7% in the third quarter, best quarterly performance ever for the Group
October 16, 2025